You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 19, 2024

Methocarbamol - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for methocarbamol and what is the scope of freedom to operate?

Methocarbamol is the generic ingredient in five branded drugs marketed by Dr Reddys, Marsam Pharms Llc, Am Regent, Baxter Hlthcare Corp, Eugia Pharma, Fresenius Kabi Usa, Gland Pharma Ltd, Monterey Pharms Llc, Mylan Institutional, Navinta Llc, Sagent Pharms Inc, Slate Run Pharma, Somerset Theraps Llc, Hikma, Ferndale Labs, Forest Labs, Able, Acme Labs, Am Therap, Ani Pharms, Ascot, Aurobindo Pharma Ltd, Austarpharma Llc, Beximco Pharms Usa, Chartwell Molecular, Clonmel Hlthcare, Fosun Pharma, Granules, Heather, Hetero Labs Ltd Iii, Hikma Intl Pharms, Impax Labs, Inwood Labs, Ivax Sub Teva Pharms, Kv Pharm, Mikart, MLV, Mylan, Nylos, Oxford Pharms, Pioneer Pharms, Prinston Inc, Puracap Pharm, Purepac Pharm, Roxane, Sandoz, Solvay, Sun Pharm Industries, Superpharm, Tablicaps, Upsher Smith, Watson Labs, and Auxilium Pharms Llc, and is included in seventy-four NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-seven drug master file entries for methocarbamol. Fifty-eight suppliers are listed for this compound.

Drug Prices for methocarbamol

See drug prices for methocarbamol

Drug Sales Revenue Trends for methocarbamol

See drug sales revenues for methocarbamol

Recent Clinical Trials for methocarbamol

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Arthritis Innovation CorporationPhase 3
AllucentPhase 3
Prisma Health-UpstatePhase 4

See all methocarbamol clinical trials

Pharmacology for methocarbamol
Medical Subject Heading (MeSH) Categories for methocarbamol

US Patents and Regulatory Information for methocarbamol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Oxford Pharms METHOCARBAMOL methocarbamol TABLET;ORAL 040489-002 Jan 29, 2003 AA RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Granules METHOCARBAMOL methocarbamol TABLET;ORAL 209312-001 May 7, 2018 AA RX No Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Watson Labs METHOCARBAMOL methocarbamol TABLET;ORAL 083605-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Aurobindo Pharma Ltd METHOCARBAMOL methocarbamol TABLET;ORAL 213967-001 Aug 12, 2020 AA RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.